Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-05-11

Clinical Trial Update: Sex Hormone Binding Globulin, Testosterone and Glycemic Control in Patients With Type 2 Diabetes

View source ↗

Summary

This clinical trial update reports completion of a study investigating the relationship between sex hormone binding globulin, testosterone, and glycemic control…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TESTOSTERONE (testosterone)

Snippet

Sponsor: Nanjing First Hospital, Nanjing Medical University | Conditions: Type2 Diabetes | Status: COMPLETED